$SOL This round is truly a textbook case of retail investors being caught: institutions quietly built positions earlier, then started dumping at around $200 to FOMO retail investors. At this point, it's basically just a bunch of high-position trapped investors comforting each other.
Those who really understand have already reduced their positions in batches in the 180-190 range. Those still shouting "SOL ecosystem is amazing" are either trapped or looking for a greater fool. That's just how the market works; everyone is a genius when prices rise, but only then do we see who is swimming naked when prices fall.
The weight of the vehicle is not important; the key is who is sitting inside. Now SOL is filled with retail investors who have bought at high prices; wanting to drive smoothly? First, you need to shed these burdens.
From a technical perspective, Injective does face obvious short-term pressure, but this decline seems more like a ripple effect of market adjustments. The concept of multiple virtual machines should perform well in the mid-bull market, just like the last explosion in the Cosmos ecosystem.
In terms of RWA integration, Injective's institutional collaborations are indeed progressing steadily, but the market hasn't fully bought into this narrative yet. The token burn mechanism is a highlight; the deflationary model can often provide additional support when liquidity tightens.
However, to be honest, at this point in time, Layer 1s are all competing on ecosystem data and TVL growth. Although Injective's fundamentals are solid, it still needs stronger topics to attract capital back in a market dominated by attention economics.
Looking at the technicals in the short term and ecological development in the medium term, this logic is quite clear.
